Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Principal factor analysis of p...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
اكتمل التصدير —
Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.
Manylion Llyfryddiaeth
Prif Awduron:
Generali, D
,
Fox, S
,
Buffa, F
,
Berruti, A
,
Brizzi, M
,
Allevi, G
,
Bonardi, S
,
Dogliotti, L
,
Bottini, A
,
Harris, A
Fformat:
Conference item
Cyhoeddwyd:
2006
Daliadau
Disgrifiad
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
gan: Generali, D, et al.
Cyhoeddwyd: (2006)
Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
gan: Generali, D, et al.
Cyhoeddwyd: (2006)
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
gan: Generali, D, et al.
Cyhoeddwyd: (2009)
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
gan: Mele, T, et al.
Cyhoeddwyd: (2010)
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
gan: Mele, T, et al.
Cyhoeddwyd: (2010)